Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19

Project Title Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19
Date Posted
Monday, April 20, 2020
Status
In progress
Description

This study aims to sequentially monitor priority drugs for the care of patients hospitalized with COVID-19, including sedatives and drugs used to assist with mechanical ventilation, therapies for respiratory diseases, thrombolytics, anticoagulants, anti-infectives, opioid analgesics, and other drugs used to treat COVID-19. Drug utilization in the outpatient care setting will also be examined. The purpose of this activity is to assess changing patterns of use to support regional assessments of drug use and to assess for drug shortages.

Workgroup Leader(s)

Sruthi Adimadhyam, PhD; Judith Maro, PhD; Jeffery Brown, PhD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Michael Nguyen, MD; Grace Chai, PharmD; Corinne Woods, RPh, MPH; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

Workgroup Members

Katie Haffenreffer; Soowoo Back, MPH; Casie Horgan, MPH; Jennifer Noble; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Robert Ball, MD, MPH, ScM; Catherine Corey; Gerald Dal Pan, MD, MHS; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

Project ID
covid_ahr_wp001
Population / Cohort
All individuals
Time Period
March 2020 – Current
Data Sources
Select Sentinel Data Partners
Related Links
Scroll to Top